Select Medical Holdings (NYSE: SEM) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.27 billion.

GUIDANCE:

Select Medical Holdings sees FY2019 EPS of $0.97-$1.13, versus the consensus of $1.10.

Select Medical reaffirms its 2019 business outlook, provided most recently in its January 4, 2019 press release, for net operating revenues, Adjusted EBITDA and fully diluted earnings per common share. Select Medical continues to expect consolidated net operating revenues for the full year 2019 to be in the range of $5.2 billion to $5.4 billion. Select Medical continues to expect Adjusted EBITDA for the full year 2019 to be in the range of $660.0 million to $700.0 million. Select Medical continues to expect fully diluted earnings per common share for the full year 2019 to be in the range of $0.97 to $1.13.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.